Arsenic cancer risk confounder in Southwest Taiwan data set

Environmental Health Perspectives

Volumn 114, Issue 7, 2006, Pages 1077-1082

  Lamm, Steven H ^a,b,c   Engel, Arnold ^b   Penn, Cecilia A ^a,b   Chen, Rusan ^d   Feinleib, Manning ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Center for Epidemiology and Global Health   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Arsenic; Blackfoot disease; Bladder cancer; Cancer risk; Confounder; Dose response relationship; Southwest Taiwan; Threshold model

Indexed keywords

ARSENIC DERIVATIVE;

ANALYSIS OF VARIANCE; ARTICLE; BLACKFOOT DISEASE; BLADDER CANCER; CANCER MORTALITY; CANCER RISK; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TAIWAN;

ARSENIC; ARSENIC POISONING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; NEOPLASMS; RISK FACTORS; TAIWAN;

EID: 33745778228     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8704     Document Type: Article

References (28)

1. Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Laman D, et al. 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 159(4):381-389.
2. Bates MN, Smith A, Cantor KP. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141(6):523-530.
3. Brown KG, Chen CJ. 1995. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Anal 15(4):475-484.
4. Carnegie Mellon University. StatLib. Available: http://lib.stat.cmu.edu/ [accessed 7 May 2006].
5. Chen CJ, Chen CW, Wu MM, Kuo TL. 1992. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892.
6. Chen CJ, Chuang YC, Lin TM, Wu HY. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic well water and cancers. Cancer Res 45:5895-5899.
7. Chen KP, Wu HY. 1962. Epidemiologic studies on blackfoot disease: 2. A study of source of drinking water in relation to the disease. J Formosan Med Assoc 61(7):611-618.
8. Chen KP, Wu HY, Wu TC. 1962. Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas. Mem Coll Med Nat Taiwan Univ 8(1-2):115-129.
9. Ch'i IC, Blackwell RQ. 1968. A controlled retrospective study of blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol 88(1):7-24.
10. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, et al. 2001. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153(5):411-418.
11. Cohen SM. 2002. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol Pathol 30(6):663-671.
12. Kuo TL. 1968. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Rep Inst Pathol Natl Taiwan Univ 20:7-13.
13. Lamm SH, Byrd DM, Kruse MB, Feinleib M, Lai SH. 2003. Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan. Biomed Environ Sci 16(4):355-368.
14. Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, et al. 2004. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. Counties and 30 years of observation. J Occup Environ Med 46(3): 298-306.
15. Lu FJ. 1990. Blackfoot disease: arsenic or humic acid? Lancet 336:115-116.
16. Morales KH, Ryan LM, Brown KG, Kuo TL, Chen CJ, Wu MM. 1999. Model sensitivity in an analysis of arsenic exposure and bladder cancer in southwestern Taiwan. In: Arsenic Exposure and Health Effects (Chappell WR, Abernathy C, Calderone RL, eds). Oxford, UK:Elsevier Science, 207-215.
17. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ. 2000. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 108:655-661.
18. NRC (National Research Council). 1999a. Arsenic in Drinking Water. Washington, DC:National Academy Press.
19. NRC (National Research Council). 1999b. Internal cancer data from arsenic-exposure studies conducted in Taiwan region endemic to blackfoot disease. Addendum to chapter 10. Table A10-1. In: Arsenic in Drinking Water. Washington, DC:National Academy Press, 308-309.
20. NRC (National Research Council). 2001. Arsenic in Drinking Water-2001 Update. Washington, DC:National Academy Press.
21. Schoen A, Beck B, Sharma R, Dube E. 2004. Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol Applied Pharmacol 198:253-267.
22. Snow ET, Sykora P, Durham TR, Klein CB. 2005. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? Toxicol Appl Pharmacol 207(2S):557-564.
23. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158(12):1193-1201.
24. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40(3):453-462.
25. U.S. EPA. 2001. National primary drinking water regulations; arsenic and clarification to compliance and new sources contaminants monitoring, final rule. Fed Reg 66(14): 6976-7066.
26. U.S. EPA. 2005. Issue Paper: Inorganic Arsenic Slope Factor. Final Draft. 23 July. Washington, DC:U.S. Environmental Protection Agency.
27. World Health Organization. 1965. International Classification of Diseases: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Eighth Revision. Vols 1 and 2. Geneva:World Health Organization.
28. Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancer and vascular diseases. Am J Epidemiol 130 (6):1123-1132.